Literature DB >> 16210342

T-cell non-Hodgkin lymphoma.

Mujahid A Rizvi1, Andrew M Evens, Martin S Tallman, Beverly P Nelson, Steven T Rosen.   

Abstract

T-cell non-Hodgkin lymphomas (NHLs) are uncommon malignancies. The current WHO/EORTC classification recognizes 9 distinct clinicopathologic peripheral T-cell NHLs. These disorders have unique characteristics and require individualized diagnostic and therapeutic strategies. Tremendous progress has been made in recent years in the understanding of the pathogenesis of these disorders. Specific chromosomal translocations and viral infections are now known to be associated with certain lymphomas. In this review, we describe their clinical and pathologic features. We also discuss the use of molecular studies in the diagnostic work-up of T-cell lymphomas. Because of the rarity of these disorders and the lack of well-designed clinical trials, the treatment of peripheral T-cell NHLs is often challenging. Additional studies are required to learn more about the biology of these diseases, which may lead to more optimal and possibly targeted therapies.

Entities:  

Mesh:

Year:  2005        PMID: 16210342     DOI: 10.1182/blood-2005-03-1306

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  56 in total

Review 1.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified.

Authors:  Agustin Avilés; Claudia Castañeda; Natividad Neri; Sergio Cleto; Alejandra Talavera; Martha González; Judith Huerta-Guzmán; M Jesús Nambo
Journal:  Med Oncol       Date:  2008-02-05       Impact factor: 3.064

Review 3.  Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Akira Satou; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2019-07-31       Impact factor: 2.929

4.  Peripheral T-cell lymphoma presenting as an ischemic stroke in a 23-year-old woman: a case report and review of the literature.

Authors:  Mariantina Fragou; Dimitrios Karakitsos; Alexandros Kalogeromitros; George Samonis; Andreas Karabinis
Journal:  J Med Case Rep       Date:  2009-10-27

5.  Romidepsin: in the treatment of T-cell lymphoma.

Authors:  Lily P H Yang
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

6.  Polymorphisms in microRNA-related genes are associated with survival of patients with T-cell lymphoma.

Authors:  Xi Li; Xiaobo Tian; Bo Zhang; Jieping Chen
Journal:  Oncologist       Date:  2014-02-21

7.  Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.

Authors:  Porcia T Bradford; Susan S Devesa; William F Anderson; Jorge R Toro
Journal:  Blood       Date:  2009-03-11       Impact factor: 22.113

8.  The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

Authors:  Dashnamoorthy Ravi; Savita Bhalla; Ronald B Gartenhaus; Jennifer Crombie; Irawati Kandela; Jaya Sharma; Andrew Mazar; Andrew M Evens
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

9.  Primary Gastro Intestinal Lymphoma Presenting as Perforation Peritonitis.

Authors:  Suhaib Abdul Rehaman; Chandrashekar Shastry Ramachandra; Reuben Prakash Jackaya
Journal:  J Clin Diagn Res       Date:  2016-03-01

10.  Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma.

Authors:  Daisuke Shimizu; Tomohiko Taki; Atae Utsunomiya; Hitoshi Nakagawa; Kenichi Nomura; Yosuke Matsumoto; Kazuhiro Nishida; Shigeo Horiike; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.